基本信息
浏览量:4
职业迁徙
个人简介
Mieke Van Hemelrijck leads the Translational Oncology and Urology Research (TOUR) Team in the School of Cancer & Pharmaceutical Sciences at King's. She became a Reader (Associate Professor) in Cancer Epidemiology in September 2018, and became a Professor in late 2020. She joined the Group in August 2008 from Harvard School of Public Health to study for her PhD on 'Metabolic Syndrome and Prostate Cancer: Biomarkers and Treatment Side-effects', which she completed in November 2010. At Harvard, her Master's thesis focused on bladder cancer and smoking patterns, building on her Master's in Statistical Data-Analysis received from Ghent University in her home country of Belgium in 2006.
As a cancer epidemiologist working with national registers and hospital-based (biobank) data in the UK and Europe, Prof Van Hemelrijck has expertise in clinical data, statistics, clinical practice and patient care in the area of uro-oncology. Moreover, several of her PhD students and staff are conducting qualitative research into understanding patients’ needs and experiences (e.g. development of educational support tool for men with prostate cancer on active surveillance; development of an exercise intervention as part of standard care for men with prostate cancer). Furthermore, Prof Van Hemelrijck has worked with Movember on developing a consensus document on semantics in active surveillance for men with prostate cancer using a modified Delphi consensus procedure. Most recently, Prof Van Hemelrijck started working with the European Association of Urology (EAU) Guidelines Office as part of the EU-funded PIONEER Consortium – big data for prostate cancer. She is leading the work package that aims to develop standardised definitions of prostate cancer outcomes among different stakeholders using the Delphi consensus procedure. Prof Van Hemelrijck’s prostate cancer research is internationally recognised and she is currently also involved in another large international Consortim: ReIMAGINE
Given Mieke’s interest in clinical epidemiology of urological cancers, she has coordinated the King’s Health Partners' Uro-Oncology Programme, which brings together all researchers and clinicians involved in urological cancer research at KHP since 2012. In 2013, she became a Visiting Researcher at the Institute of Environmental Medicine, Karolinska Institute, Stockholm, funded by a Swedish Council for Working Life and Social Research Fellowship.
Since 2008, Mieke has supervised more than 40 postgraduate and undergraduate students at King's, as well as being first supervisor currently for three PhD students in the TOUR team. Her teaching experience covers the two BSc Modules (Principles of Epidemiology and Sports, Exercise, Health, and Medicine I) hosted by the Faculty of Life Sciences and Medicine. She has published more than 240 original articles, of which she is first author on over 40 and last author on over 100.
As a cancer epidemiologist working with national registers and hospital-based (biobank) data in the UK and Europe, Prof Van Hemelrijck has expertise in clinical data, statistics, clinical practice and patient care in the area of uro-oncology. Moreover, several of her PhD students and staff are conducting qualitative research into understanding patients’ needs and experiences (e.g. development of educational support tool for men with prostate cancer on active surveillance; development of an exercise intervention as part of standard care for men with prostate cancer). Furthermore, Prof Van Hemelrijck has worked with Movember on developing a consensus document on semantics in active surveillance for men with prostate cancer using a modified Delphi consensus procedure. Most recently, Prof Van Hemelrijck started working with the European Association of Urology (EAU) Guidelines Office as part of the EU-funded PIONEER Consortium – big data for prostate cancer. She is leading the work package that aims to develop standardised definitions of prostate cancer outcomes among different stakeholders using the Delphi consensus procedure. Prof Van Hemelrijck’s prostate cancer research is internationally recognised and she is currently also involved in another large international Consortim: ReIMAGINE
Given Mieke’s interest in clinical epidemiology of urological cancers, she has coordinated the King’s Health Partners' Uro-Oncology Programme, which brings together all researchers and clinicians involved in urological cancer research at KHP since 2012. In 2013, she became a Visiting Researcher at the Institute of Environmental Medicine, Karolinska Institute, Stockholm, funded by a Swedish Council for Working Life and Social Research Fellowship.
Since 2008, Mieke has supervised more than 40 postgraduate and undergraduate students at King's, as well as being first supervisor currently for three PhD students in the TOUR team. Her teaching experience covers the two BSc Modules (Principles of Epidemiology and Sports, Exercise, Health, and Medicine I) hosted by the Faculty of Life Sciences and Medicine. She has published more than 240 original articles, of which she is first author on over 40 and last author on over 100.
研究兴趣
论文共 403 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Julia Steinberg,Suzanne Hughes, Harriet Hui,Matthew J. Allsop,Sam Egger,Michael David,Michael Caruana, Peter Coxeter, Chelsea Carle,Tonia Onyeka, Isabel Rewais, Maria J. Monroy Iglesias,
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2024): 100715-100715
BJUI COMPASSno. 1 (2023): 104-113
BMJ Openno. 10 (2023): e076621-e076621
引用0浏览0引用
0
0
M.J. Monroy Iglesias,A. Santaolalla,S. Martin, B. North,B. Russell,C. Moss,G. Jones, L. Steward, C. Murtagh, C. Fernandes Cargaleiro, F. Bruno, J. Millwaters,
ESMO Openno. 1 (2023): 101910-101910
BMJ Oncologyno. 1 (2023): e000057-e000057
Steven Maclennan,Lisa M. Wintner,Katharina Beyer, Ailbhe Lawlor,Sheela Tripathee,Saeed Dabestani,Lorenzo Marconi,Rachel H. Giles, Rose Woodward,Mieke Van Hemelrijck,Axel Bex,Patricia Zondervan
BJUI COMPASSno. 5 (2023): 504-512
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn